<?xml version='1.0' encoding='utf-8'?>
<document id="21513616"><sentence text="Postmortem femoral blood concentrations of amlodipine."><entity charOffset="43-53" id="DDI-PubMed.21513616.s1.e0" text="amlodipine" /></sentence><sentence text="Postmortem femoral blood concentrations of the calcium blocker amlodipine were determined by LC-MS-MS and compiled for the years 2003-2010"><entity charOffset="47-54" id="DDI-PubMed.21513616.s2.e0" text="calcium" /><entity charOffset="63-73" id="DDI-PubMed.21513616.s2.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.21513616.s2.e0" e2="DDI-PubMed.21513616.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21513616.s2.e0" e2="DDI-PubMed.21513616.s2.e1" /></sentence><sentence text=" The cause of death was classified as unrelated to amlodipine in 38 cases in which the concentration ranged from 0"><entity charOffset="51-61" id="DDI-PubMed.21513616.s3.e0" text="amlodipine" /></sentence><sentence text="006 to 0" /><sentence text="13 mg/kg (median 0" /><sentence text="048 mg/kg), a range that exceeds published in vivo therapeutic serum levels by several-fold" /><sentence text=" In three cases, amlodipine was judged to be a contributing factor to death and concentrations ranged from 0"><entity charOffset="17-27" id="DDI-PubMed.21513616.s7.e0" text="amlodipine" /></sentence><sentence text="29 to 0" /><sentence text="44 mg/kg" /><sentence text=" This concentration range is of the same order of magnitude as published serum levels for clinical toxicity cases" /><sentence text=" One fatality was ascribed to amlodipine poisoning with a concentration of 0"><entity charOffset="30-40" id="DDI-PubMed.21513616.s11.e0" text="amlodipine" /></sentence><sentence text="90 mg/kg, which is similar to values observed in previously published fatality cases" /><sentence text=" One suspected drug-drug interaction case in which the amlodipine level (0"><entity charOffset="55-65" id="DDI-PubMed.21513616.s13.e0" text="amlodipine" /></sentence><sentence text="17 mg/kg) was considered elevated due to inhibition of the cytochrome P450 3A4 enzyme by the azole antifungal drug, fluconazole, was detected"><entity charOffset="93-98" id="DDI-PubMed.21513616.s14.e0" text="azole" /><entity charOffset="116-127" id="DDI-PubMed.21513616.s14.e1" text="fluconazole" /><entity charOffset="122-132" id="DDI-PubMed.21513616.s14.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.21513616.s14.e0" e2="DDI-PubMed.21513616.s14.e0" /><pair ddi="false" e1="DDI-PubMed.21513616.s14.e0" e2="DDI-PubMed.21513616.s14.e1" /><pair ddi="false" e1="DDI-PubMed.21513616.s14.e0" e2="DDI-PubMed.21513616.s14.e2" /><pair ddi="false" e1="DDI-PubMed.21513616.s14.e1" e2="DDI-PubMed.21513616.s14.e1" /><pair ddi="false" e1="DDI-PubMed.21513616.s14.e1" e2="DDI-PubMed.21513616.s14.e2" /></sentence><sentence text=" In conclusion, it is important to establish postmortem reference concentrations rather than relying on in vivo therapeutic serum levels, which may be too low and lead to false conclusions in postmortem cases" /><sentence text="" /></document>